Atlas Trials

Investigating the Clinical Consequences of Flutemetamol-PET-scanning

Clinical trial NCT02353949 · TERMINATED

Trial details

NCT number
NCT02353949
Sponsor
University of Zurich
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Mild Cognitive ImpairmentAlzheimer's DiseaseDementia
Start date
2015-05-01
Primary completion
2019-12-10
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.